Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning
Completed
Bracco Diagnostics, Inc
2011-09-01
This study will be performed at clinical sites that have administered CardioGen-82® to
patients from January to July 2011. The patients enrolled(i.e., "target date patients") will
be all those who were dosed at the end of use of the CardioGen-82® generators on the last day
of generator use from the generator that was used immediately prior to the recalled generator
(i.e., "target date generators"). These are not patients who received drug eluted from the
recalled generator. Of these patients, it is planned that 100 patients will be entered in
this trial.
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites
Completed
Bracco Diagnostics, Inc
2011-09-01
This study is to be performed at two clinical sites where patients received CardioGen-82
during the time period January to June, 2011 and where patients were scanned chronologically
near to the index patients (2 days before or after). Of these, it is planned that at least 30
patients will be entered in this trial. Index patient is the term applied to individuals who
had radiation spectra indicative of Sr-82 and Sr-85 detected by hand-held survey meters.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
